Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Bipolar H.A Versus Trochanteric Antegrade Nail for Treatment of Displaced Subcapital Femoral Fractures

NCT01181037 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

NCT NCT01181037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01181037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Bipolar H.A Versus Trochanteric Antegrade Nail for Treatment of Displaced Subcapital Femoral Fractures
Lead sponsor
Meir Medical Center
Phase
Observational
Overall status
Unknown status
Start date
June 30, 2010
Completion date
April 30, 2012
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

displaced subcapital femoral fracture